![Charles Sigal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Charles Sigal
Directeur/Membre du Conseil chez
VIR BIOTECHNOLOGY, INC.
Fortune : 1 M $ au 31/05/2026
Profil
Dr. Charles E.
Sigal is an Independent Director at Alnylam Pharmaceuticals, Inc., an Independent Director at Vir Biotechnology, Inc., an Independent Director at Affinia Therapeutics, Inc., a Manager at Segal Family Investments LLC, a Member-Drug Discovery & Development Forum at National Academy of Medicine (United States) and a Member-President Council at The J.
David Gladstone Institutes.
He is on the Board of Directors at Alnylam Pharmaceuticals, Inc., Tessera Therapeutics, Inc., Vir Biotechnology, Inc., Affinia Therapeutics, Inc., Melanoma Research Alliance, Medarex, Inc. and University Medical Center.
Dr. Sigal was previously employed as an Independent Non-Executive Director by Surface Oncology, Inc., an Independent Non-Executive Director by Adaptimmune Therapeutics Plc, a Non-Executive Director by Adaptimmune Ltd., an Independent Director by Spark Therapeutics, Inc., a Director, Chief Scientific Officer & Executive VP by Bristol Myers Squibb Co., a Chief Executive Officer, Vice President-R&D by Mercator Genetics, Inc., and a Trustee by Penn Medicine Princeton Health.
He also served on the board at Mead Johnson Nutrition Co. He received his undergraduate degree from Purdue University, a graduate degree from Purdue University, a doctorate degree from The University of Chicago and a doctorate degree from Purdue University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 20/05/2026 | 2 775 ( 0 % ) | 837 995 $ | 31/05/2026 | |
VIR BIOTECHNOLOGY, INC. 0,02 % | 27/05/2026 | 39 806 ( 0,02 % ) | 379 749 $ | 31/05/2026 |
Postes actifs de Charles Sigal
| Sociétés | Poste | Début |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Directeur/Membre du Conseil | 02/07/2020 |
| ALNYLAM PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 22/08/2022 |
Melanoma Research Alliance
 Melanoma Research Alliance Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Directeur/Membre du Conseil | 01/11/2013 |
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | Directeur/Membre du Conseil | 15/06/2021 |
Affinia Therapeutics, Inc.
 Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Directeur/Membre du Conseil | 08/06/2020 |
Segal Family Investments LLC | Corporate Officer/Principal | - |
National Academy of Medicine (United States)
 National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Corporate Officer/Principal | - |
The J. David Gladstone Institutes
 The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology | Corporate Officer/Principal | - |
Medarex, Inc.
 Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Directeur/Membre du Conseil | - |
| ░░░░░░░░░░ ░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Charles Sigal
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░ ░░░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Charles Sigal
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
Bristol Myers Squibb Co.
 Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products | Health Technology |
Medarex, Inc.
Medarex, Inc. BiotechnologyHealth Technology Provides antibody and oncology drug development services | Health Technology |
Mead Johnson Nutrition Co.
 Mead Johnson Nutrition Co. Food: Meat/Fish/DairyConsumer Non-Durables Produces infant and children's nutrition products | Consumer Non-Durables |
Mercator Genetics, Inc.
 Mercator Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops gene therapy programs for asthma, schizophrenia and cancer | Commercial Services |
Alnylam Pharmaceuticals, Inc.
 Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Purdue University
 Purdue University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Penn Medicine Princeton Health
 Penn Medicine Princeton Health Hospital/Nursing ManagementHealth Services Provides health care services | Health Services |
National Academy of Medicine (United States)
National Academy of Medicine (United States) Miscellaneous Commercial ServicesCommercial Services Operates as a professional membership organization | Commercial Services |
The J. David Gladstone Institutes
The J. David Gladstone Institutes Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology | Commercial Services |
University Medical Center
 University Medical Center Medical/Nursing ServicesHealth Services Operates as medical group | Health Services |
Adaptimmune Ltd.
 Adaptimmune Ltd. Medical/Nursing ServicesHealth Services Focuses on the use of T cell therapy to treat cancer and infectious diseases | Health Services |
Spark Therapeutics, Inc.
 Spark Therapeutics, Inc. BiotechnologyHealth Technology Develops therapy products for debilitating diseases | Health Technology |
Melanoma Research Alliance
Melanoma Research Alliance Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Surface Oncology, Inc.
 Surface Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage immuno-oncology company that develops cancer therapies | Health Technology |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
Segal Family Investments LLC | |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Affinia Therapeutics, Inc.
Affinia Therapeutics, Inc. BiotechnologyHealth Technology Develops adeno-associated virus gene therapies | Health Technology |
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | Health Technology |
